Citius Oncology Inc. (CTOR)
NASDAQ: CTOR
· Real-Time Price · USD
1.76
0.07 (4.14%)
At close: Aug 18, 2025, 3:59 PM
1.79
1.69%
After-hours: Aug 18, 2025, 05:58 PM EDT
4.14% (1D)
| Bid | 1.7 |
| Market Cap | 137.93M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -14.39M |
| EPS (ttm) | -0.39 |
| PE Ratio (ttm) | -4.51 |
| Forward PE | 36 |
| Analyst | Hold |
| Ask | 1.85 |
| Volume | 97,054 |
| Avg. Volume (20D) | 1,932,896 |
| Open | 1.69 |
| Previous Close | 1.69 |
| Day's Range | 1.69 - 1.78 |
| 52-Week Range | 0.55 - 6.19 |
| Beta | 3.02 |
About CTOR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTOR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTOR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-31.21%
Citius Oncology shares are trading lower after the...
Unlock content with
Pro Subscription
2 months ago
+4.32%
CTOR stock has given up its prior gain. Citius Oncology shares were trading higher after the company said it expects the commercial launch LYMPHIR in the second half of 2025.